Angelo Avogaro on Muck Rack

Angelo Avogaro

Italy
As seen in: Color Research & Application, Wiley Online Library, BMJ Open Diabetes Research & Care, MDPI, Il Messaggero, Medscape, The Lancet, Diabetes Care Magazine, Corriere Adriatico, Quotidiano di Puglia and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Angelo

Contact Angelo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Revisiting the burden and patterns of myocardial infarction in type 1 diabetes

|
By Angelo Avogaro, Gian Paolo Fadini
| The Lancet Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Smidtslund, P ∙ Harjutsalo, V ∙ Thorn, V ∙ et al. Comparison of incidence patterns and risk profiles of ST-elevation and non-ST-elevation myocardial infarction in type 1 diabetes in Finland: a nationwide cohort study Lancet Diabetes Endocrinol. 2025; 2.
Open in Who Shared Issue with article?

Beyond glycemic control: How incretins are changing the cardiovascular trajectories of diabetes and obesity

|
By Angelo Avogaro
| Wiley Online Library Verified
1 INTRODUCTION Diabetes mellitus poses a major global health challenge due to its wide spectrum of debilitating complications. Both microvascular and macrovascular sequelae significantly contribute to morbidity, disability and premature mortality.1 The global rise in diabetes parallels—and is partly driven by—the rapid expansion of obesity.
Open in Who Shared Issue with article?

Incretins and the cardiovascular system: bridging digestion with metabolism

|
By Angelo Avogaro, Gian Paolo Fadini
| The Lancet Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Badve, SV ∙ Bilal, A ∙ Lee, MMY ∙ et al. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials Lancet Diabetes Endocrinol. 2025; 13:15-28 2. Fadini, GP ∙ Sciannameo, V ∙ Franzetti, I ∙ et al.
Open in Who Shared Issue with article?
See all 31 licensed articles (32 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified